CS logo
small CS logo
Getwell Hospital and Research Institute

Nagpur, Maharashtra, India
General hospital in Nagpur, Maharashtra
1, 20, Dr, Khare Marg, Dhantoli, Nagpur, Maharashtra 440012

About Getwell Hospital and Research Institute


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
3
Boehringer Ingelheim
2
Eisai Pharmaceuticals India Pvt. Ltd
1
Gilead Sciences
1
Glenmark Pharmaceuticals Ltd. India
1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
1
Total Rows: 6

Clinical Trials at Getwell Hospital and Research Institute


During the past decade, Getwell Hospital and Research Institute conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
2011-10-01
2013-04-01
Completed
273
A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone
2012-06-01
2013-10-01
Completed
442
A Safety, Efficacy and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric and Adult Subjects With Primary Generalized Tonic-Clonic (i.e., Grand Mal) Seizures.
2013-04-03
2019-02-20
Completed
219
A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis
2015-11-12
2018-11-28
Completed
580
A Trial to Evaluate the Safety of Long Term Treatment With Nintedanib in Patients With Scleroderma Related Lung Fibrosis
2017-11-27
2023-01-25
Completed
444
A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine
2018-03-14
2026-11-30
Recruiting
325
A Study to Assess Safety and Efficacy of Perampanel in Indian Participants as an Adjunctive Treatment in Partial Onset Seizures With or Without Secondary Generalized Seizures in Participants With Epilepsy Aged 12 Years or Older
2019-02-18
2020-03-01
Completed
200
A Study of Galcanezumab (LY2951742) in Participants With Episodic Migraine
2019-07-30
2022-03-11
Completed
520

Rows per page:

1–9 of 9

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Getwell Hospital and Research Institute" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Eisai Pharmaceuticals India Pvt. Ltd" with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "Glenmark Pharmaceuticals Ltd. India" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Getwell Hospital and Research Institute" #1 collaborator was "Glenmark Pharmaceuticals S.A." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Getwell Hospital and Research Institute


According to Clinical.Site data, the most researched conditions in "Getwell Hospital and Research Institute" are "Episodic Migraine" (2 trials), "Asthma" (1 trials), "Chronic Migraine" (1 trials), "Epilepsy" (1 trials) and "Generalized Tonic Clonic Seizures" (1 trials). Many other conditions were trialed in "Getwell Hospital and Research Institute" in a lesser frequency.

Clinical Trials Intervention Types at Getwell Hospital and Research Institute


Most popular intervention types in "Getwell Hospital and Research Institute" are "Drug" (9 trials) and "Behavioral" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Galcanezumab" (3 trials), "Nintedanib" (2 trials), "Diet" (1 trials) and "Exercise" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Getwell Hospital and Research Institute


The vast majority of trials in "Getwell Hospital and Research Institute" are 9 trials for "All" genders.

Clinical Trials Status at Getwell Hospital and Research Institute


Currently, there are NaN active trials in "Getwell Hospital and Research Institute". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Getwell Hospital and Research Institute, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Getwell Hospital and Research Institute, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status